Neurones S.A. (EPA: NRO)
France flag France · Delayed Price · Currency is EUR
43.10
-0.10 (-0.23%)
Aug 30, 2024, 5:35 PM CET

Neurones Statistics

Total Valuation

Neurones has a market cap or net worth of EUR 1.05 billion. The enterprise value is 845.97 million.

Market Cap 1.05B
Enterprise Value 845.97M

Important Dates

The next estimated earnings date is Wednesday, September 11, 2024.

Earnings Date Sep 11, 2024
Ex-Dividend Date Jun 12, 2024

Share Statistics

Neurones has 24.27 million shares outstanding.

Shares Outstanding 24.27M
Shares Change (YoY) n/a
Shares Change (QoQ) n/a
Owned by Insiders (%) 63.75%
Owned by Institutions (%) 15.88%
Float 8.80M

Valuation Ratios

The trailing PE ratio is 21.23 and the forward PE ratio is 20.76.

PE Ratio 21.23
Forward PE 20.76
PS Ratio 1.41
PB Ratio 2.95
P/FCF Ratio 19.34
PEG Ratio n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.34, with an EV/FCF ratio of 15.64.

EV / Earnings 17.12
EV / Sales 1.14
EV / EBITDA 9.34
EV / EBIT 11.33
EV / FCF 15.64

Financial Position

The company has a current ratio of 2.38, with a Debt / Equity ratio of 10.78.

Current Ratio 2.38
Quick Ratio 2.33
Debt / Equity 10.78
Debt / EBITDA 0.49
Debt / FCF 0.81
Interest Coverage 52.09

Financial Efficiency

Return on equity (ROE) is 14.95% and return on invested capital (ROIC) is 10.82%.

Return on Equity (ROE) 14.95%
Return on Assets (ROA) 7.23%
Return on Capital (ROIC) 10.82%
Revenue Per Employee 109,820
Profits Per Employee 7,321
Employee Count 6,749
Asset Turnover 1.15
Inventory Turnover 742.79

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +14.32% in the last 52 weeks. The beta is 0.59, so Neurones's price volatility has been lower than the market average.

Beta (5Y) 0.59
52-Week Price Change +14.32%
50-Day Moving Average 42.72
200-Day Moving Average 43.94
Relative Strength Index (RSI) 50.07
Average Volume (20 Days) 3,847

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Neurones had revenue of EUR 741.18 million and earned 49.41 million in profits. Earnings per share was 2.03.

Revenue 741.18M
Gross Profit 346.76M
Operating Income 74.69M
Pretax Income 80.77M
Net Income 49.41M
EBITDA 82.72M
EBIT 74.69M
Earnings Per Share (EPS) 2.03

Balance Sheet

The company has 297.76 million in cash and 43.98 million in debt, giving a net cash position of 253.78 million or 10.45 per share.

Cash & Cash Equivalents 297.76M
Total Debt 43.98M
Net Cash 253.78M
Net Cash Per Share 10.45
Equity (Book Value) 407.91M
Book Value Per Share 14.60
Working Capital 316.89M

Cash Flow

In the last 12 months, operating cash flow was 72.08 million and capital expenditures -17.98 million, giving a free cash flow of 54.09 million.

Operating Cash Flow 72.08M
Capital Expenditures -17.98M
Free Cash Flow 54.09M
FCF Per Share 2.23

Margins

Gross margin is 46.78%, with operating and profit margins of 10.08% and 6.67%.

Gross Margin 46.78%
Operating Margin 10.08%
Pretax Margin 10.90%
Profit Margin 6.67%
EBITDA Margin 11.16%
EBIT Margin 10.08%
FCF Margin 7.30%

Dividends & Yields

This stock pays an annual dividend of 1.20, which amounts to a dividend yield of 2.78%.

Dividend Per Share 1.20
Dividend Yield 2.78%
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio 53.93%
Buyback Yield n/a
Shareholder Yield 2.78%
Earnings Yield 4.71%
FCF Yield 5.17%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a